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A rapid, easy assay for monitoring dynamics of T-cell activation should help to guide potential medical
evaluation of immune responses or immunopathogenesis. Here, we report development of novel
electrochemical cytosensors for dynamic analyses of T-cell activation markers on living cells. Gold
nanoparticles-doped polyaniline nanoﬁber (Au/PANI-NFs) composite was greenly prepared by in situ
one-step chemical inertness of PANI-NFs with gold nanoparticles to fabricate impedance-based
electrochemical biosensors. Transmission electron micrographs indicated that the gold nanoparticles
were uniformly anchored along with the structure of PANI-NF surface, displaying ﬁbrillar morphology
with a ∼60 nm diameter. Au/PANI-NFs-based cytosensors coated with anti-CD Ab molecules could
provide biomimetic interface for multiple immunosensing of T-cell surface activation markers (CD69,
CD25, and CD71). The dual signal ampliﬁcation of Au nanoparticle and PANI-NFs-based electrochemical
impedance spectroscopic (EIS) measurements enabled the cytosensors considerably sensitive, with a
detection limit of 1104 cells/ml of activated T-cells. The activation-targeted cytosensors detected early,
middle and late stages for expression of activation markers CD69, CD25, and CD71 at 8 h, 24 h, and 36 h,
respectively, after concanvalin A stimulation of T cells. The quantitative results consisted with those
derived from ﬂow cytometric analysis. Furthermore, activation-targeted cytosensor allowed for dynamic
analysis of the immune inhibition of T-cell activation by immune regulatory drug icariin (ICA). Thus, Au/
PANI-NFs-based cytosensors offer simple and fast approach for non-destructive, quantitative evaluation
of T-cell activation markers, with considerable speciﬁcity, reproducibility, and low background noise.
& 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Certain clusters of differentiation (CD) molecules serve as
surrogate markers for T-cell activation and differentiation during
immune responses to inﬂammation, infection and cancer
(Shevach, 2000). Upon stimulation of CD3/TCR, T cells express
T-cell activation markers CD69, CD25 and CD71 (transferrin, TF),
which correspond to early, middle and late activation stages of
T-cell activation, respectively (Roncarolo and Levings, 2000;
Sakaguchi, 2000). Since abnormal patterns of T-cell activation
are associated with many diseases (Chen et al., 2008; Varma
et al., 2006), dynamic monitoring of T-cell activation markers
may help understand their roles in disease pathogenesis and
potential applications for guiding clinical evaluation.r B.V.
hen@uic.edu (Z.W. Chen).
Open access under CC BY-NC-NDFlow cytometry, ELISA, mass spectroscopy, and chromatography
are utilized as analytical techniques for T-cell activation (Matsushital
et al., 2012; Ruperez et al., 2012). Flow analysis requires complex/
laborious processes of ﬂuorescence labeling of antibody/cells, expen-
sive equipment and operating systems. In addition, ﬂow assay often
disturbs cellular intactness due to cellular ﬁxation, and speciﬁcity can
be problematic due to cellular autoﬂuorescence. Other above tech-
niques have a limited ability to dynamically analyze T-cell activation
markers on living cells because of destructive features. Recently,
electrochemical methods have emerged as simple/nondestructive
analysis of living cells (Zhang et al., 2010; Lei and Ju, 2012).
Electrochemical monitoring of cell-surface carbohydrates was possi-
ble on basis of speciﬁc recognition of cell-surface glycans by quantum
dot-labeled lectins (Han et al., 2010; Cheng et al., 2009). Due to
biotoxicity of quantum dots (Derfus et al., 2004), new nanomaterials
are searched for constructing biosensing surface. It would be
beneﬁcial to integrate a new label-free approach and new
nanomaterials-based sensor interface for monitoring T-cell activation
markers on living cells.
Polyaniline nanoﬁbers (PANI-NFs) appear more attractive
than carbon nanotubes (Huang et al., 2003; Li et al., 2009), as
PANI-NFs have a larger surface-active groups-to-volume ratio, license.
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Zhang et al., 2009). Lower cytotoxicity and better biocompatibility
of PANI-NFs (Li et al., 2006; Zhao et al., 2009) make them suitable
to construct biosensors (Xian et al., 2006; Zhai et al., 2013).
Moreover, inherence of nitrogen atoms in PANI-NFs efﬁciently
introduced chemically active sites (Huang et al., 2003) and then
anchored the metal nanoparticles (Li et al., 2009). Typically, Pt
(Yue et al., 2008) and Ni (Yang et al., 2007) nanoparticles were
successfully immobilized on nitrogen-doped nanotubes by the
ethylene glycol method. In fact, gold nanoparticles (AuNPs) were
functionally fabricated as nanocomposites (Jiang et al., 2003).
Here, we developed a convenient route to directly attach AuNPs
onto PANI-NFs, and used resulting gold nanoparticles-doped poly-
aniline nanoﬁbers (Au/PANI-NFs) as an immobilization scaffold of
anti-CD molecules to prepare sensitive immunosensors detecting
T-cell activation markers (Supp. Scheme 1). The novel anti-CD Ab-
functionalized Au/PANI-NFs-based cytosensors allowed for electro-
chemical impedance spectroscopic (EIS) measurements evaluating
expression of surface T-cell activation markers on living cells. This
work presents the ﬁrst attempt to use Au/PANI-NF
nanocomposties-based electrochemical cytosensors for multiple
detections of T-cell activation dynamics at early, middle and late
stages. Furthermore, using immune regulatory drug icariin (ICA) as
an intervention model, activation marker-targeted cytosensors
were used to dynamically analyze the inhibitory regulation of T-
cell surface activation markers.2. Materials and methods
2.1. Materials and regents
See Supplementary Data.2.2. T cells and cell culture
See Supplementary Data.2.3. Fabrications of antibody-modiﬁed Au/PANI-NFs nanocomposites
Polyaniline nanoﬁbers (PANI-NFs) were synthesized according
to the reference (Huang and Kaner, 2004). Gold nanoparticles
(AuNPs) with sizes of 20 nm were prepared by the citrate reduc-
tion method (Frens, 1973). The glassy carbon electrode (GCE, 3 mm
diameter) was polished successively with 0.3- and 0.05-μm alu-
mina slurry (Beuhler) followed by rinsing thoroughly with ultra-
pure water. After successive sonication in 1:1 nitric acid, acetone
and deionized water, the electrode was rinsed with ultra-pure
water and allowed to dry at room temperature. 10 μl of 2 mg/ml
PANI-NFs suspension was dropped on the pretreated GCE and
dried in desiccator.
10 μl of 2 mg/ml AuNPs was dropped on PANI-NFs surface and
then incubated for 2 h to form (Au/PANI-NFs)/GCE through elec-
trostatic interactions between negatively-charged AuNPs and
positively-charged PANI-NFs. 10 μl of optimal concentration of
anti-CD molecules, such as anti-CD3, anti-CD69, anti-CD25, and
anti-CD71, was respectively dropped on (Au/PANI-NFs)/GCE sur-
face and then incubated for 2 h at 37 1C to yield antibodies-
immobilized electrode. Following a rinse with 0.01 M PBS (pH
7.4), the modiﬁed electrode was soaked in 0.01 M pH 7.4 PBS
containing 2% BSA for 10 min to block the surface. After thorough
washing with 0.01 M pH 7.4 PBS, the obtained immunosensors
was stored at 4 1C prior to use. As control, (PANI-NFs)/GCE and
(Au/PANI-NFs)/GCE were similarly prepared.2.4. Apparatus and characterizations
Electrochemical measurements, including electrochemical
impedance spectroscopic (EIS) analysis and cyclic voltammograms
(CV), were performed with a CHI 660 A electrochemical analyzer
(CHI, USA). The three-electrode system was comprised of a
platinum wire as auxiliary, saturated calomel electrode as refer-
ence and GCE electrode as working electrode. EIS measurements
were obtained in 10 mM pH 7.4 PBS containing 5 mM K4Fe(CN)6,
5 mM K3Fe(CN)6 and 0.1 M KCl. The nanostructure of nanocompo-
sites was characterized by transmission electron microscopy (TEM,
Philips). Cell morphology at nanoscale was visually characterized
by an AutoProbe CP Research atomic force microscopy (AFM,
Veeco, USA) in tapping mode. All of the images were smoothed
by using the Nanoscope software (IP 2.1) in order to remove the
background noise at low frequency in scanning direction.
2.5. Analytical procedures by electrochemical cytosensor
A suspension of resting or activated T-cells at a given concen-
trations was dropped on different antibody modiﬁed (Au/PANI-
NFs)/GCE for cell capture at 37 1C 1 h. After careful rinsing with
0.01 M PBS (pH 7.4), the obtained T-cell cytosensors were ready for
electrochemical measurements. The relative electron-transfer
resistance (ΔRet) was obtained by the difference between the
assay system (Ret) and the blank (Ret,o), namely, ΔRet¼Ret−Ret,o.
The data for condition optimization were the average of three
measurements.
2.6. Optimization of anti-CD Ab molecules concentrations
Anti-CD3, anti-CD69, anti-CD25 and anti-CD71 molecules were
dissolved in 0.01 M pH 7.4 PBS at different concentrations (from
0.25 μg/ml to 2.5 mg/ml); 10 μl of solutions were dropped on each
cell cytosensor, respectively. After 1 h incubation at room tempera-
ture, BSA blocking, cell capturing steps, and carefully rinsing, the
obtained cytosensors were subjected to impedance measurements.
2.7. Optimization of cell concentrations for capturing cells on
electrode surface
To demonstrate cell-concentration-dependent signal change,
antibody-immobilized electrodes were incubated for 1 h at 25 1C
with 12 μl of T-cells suspension at concentration from 5105 to
5106 cells/ml. After rinsing with 0.01 M pH 7.4 PBS, the electro-
des were subjected to impedance measurement.
2.8. Flow cytometry analysis of T-cell activation
See Supplementary Data.3. Results and discussion
3.1. Nanostructures of Au/PANI-NFs nanocomposites
We utilized TEM to investigate nanoscale interface of Au/PANI-
NFs nanocomposites. Supp. Fig. 1 shows the typical TEM images of
AuNPs, PANI-NFs, and Au/PANI-NFs, respectively. The superstruc-
tures of bamboo-like PANI-NFs were typically composed of nano-
ﬁbers of about 60–80 nm in diameter (Supp. Fig. 1a). Individual
AuNPs exhibited spherical and well-shared shape with sizes of
about 20 nm (Supp. Fig. 1b). AuNPs were homogeneously dis-
persed on the surface of PANI-NFs, forming a hybrid structure of
Au/PANI-NFs nanocomposites (Supp. Fig. 1c). Compared with
PANI-NFs, Au/PANI-NFs had uniquely surface-protuberance-like
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Fig. 1. CV (A,B,C,D) and EIS (A′,B′,C′,D′) values detected from (a) GCE, (b) (Au/PANI-NFs)/GCE, (c) antibody/(Au/PANI-NFs)/GCE and (d) T-cells/antibody/(Au/PANI-NFs)/GCE in
10 mM pH 7.4 phosphate buffered saline containing 0.1 M KCl, 5 Mm K4Fe(CN)6 and 5 mM K3Fe(CN)6. A and A′ represented changes in signals from resting T cells, whereas B,
C, D and B′, C′, and D′ displayed signals from activated T cells stimulated by ConA for 36 h.
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groups to volume and appreciable integrity with no or little
leakage of Au NPs.AuNPs were aggregated on nanoﬁber surface, and such aggre-
gation appeared to result from the chemical inertness of regular
PANI-NFs. This result suggested a strong interaction between
H. Wang et al. / Biosensors and Bioelectronics 50 (2013) 167–173170AuNPs and PANI-NFs, which might be caused by the N-
participation in their connection, a reaction that is similar to the
case of immobilizing Ag, Ni an Pt nanoparticles on nitrogen-doped
carbon nanotubes (CNx-MWNTs) (Zhao et al., 2009; Yue et al.,
2008). Additionally, the connection might be promoted further by
electrostatic interactions between negatively-charged AuNPs and
positively-charged PANI-NFs. Given that AuNPs could function as
an immobilized matrix and ﬁrmly bind antibodies presumably
through ionic interactions and other interactions between AuNPs
and mercapto or primary amine groups of antibodies (Yang et al.,
2007), Au/PANI-NFs nanocomposites appeared to offer more
homogenous surface for antibodies conjugation and, subsequently,
cells loading. In fact, we found Au/PANI-NFs nanocomposites
enhanced reproducibility of the cytosensor assay and exhibited
robust sensitivity for collecting signals.
3.2. Electrochemical features of Au/PANI-NFs-based cytosensor
The extent to which T cells bound to antibody-immobilized
electrodes was then evaluated by monitoring changes in electro-
chemical features of [Fe(CN)6]3−/4− for sensitive electrochemical
readout (Fig. 1). In the absence of Ab or cells, cyclic voltammetric
(CV) changes for (Au/PANI-NFs)/GCE were featured by detectable
signals in the working potential range (Supp. Fig. 1d), which
corresponded to the redox of [Fe(CN)6]3−/4−. When anti-CD3 Ab
molecules (curve c, Fig. 1A) and, subsequently, T-cells (curve d,
Fig. 1A) were conjugated to electrode surface, cyclic voltammo-
grams of (Au/PANI-NFs)/GCE exhibited the decreased redox peak
currents. The detection of cyclic voltammetric signals allowed us
to assess electrochemical impedance spectroscopic (EIS) signals0 50 100 150 200 250 300
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Fig. 2. EIS signals detected by activation marker-targeted cytosensors: (A) cell/anti-CD3
PANI-NFs)/GCE, (D) cell/anti-CD71/(Au/PANI-NFs)/GCE after T cells were stimulated for 0
activation may be due to the fact that CD3 molecules simply undergo rearrangement
molecules, after activation (Zhang et al., 2009).(Fig. 1A′) for more sensitive readouts measuring peak currents of
cellular activation markers captured on electrode surface. Inter-
estingly, peak currents of EIS signals for measuring cellular
activation markers on electrode surface were four times greater
than those cyclic voltammetric signals (Fig. 1A′), suggesting that
EIS sensitizing detection signals were more sensitive, and were
likely to enhance sensitivity for the proposed cytosensor. Owing to
the good stability, convenient labeling, and signal ampliﬁcation
capability of Au/PANI-NF nanocomposites, high throughput proﬁl-
ing of T-cell surface receptors or ligands could be achieved by
using unlimited antibody-conjugated Au/PANI-NFs cytosensors
targeting corresponding surface molecules.
When EIS measurements were used to monitor the change in
electron-transfer resistance (Ret) of [Fe(CN)6]3−/4− as redox probes,
the bare GCE showed a low resistance(curve a, Fig. 1A′). The
subsequent assembly of Au/PANI-NFs layer on the electrode sur-
face signiﬁcantly facilitated interfacial electron transfer (curve b,
Fig. 1A′), demonstrating that Au/PANI-NFs nanocomposites could
improve electrical connectivity of electrode, and thus signiﬁcantly
enhance detection sensitivity. After the electrode surface was
coupled by anti-CD3 Ab molecules and, subsequently blocked for
non-speciﬁc binding by BSA, an increase in Ret was observed
(curve c, Fig. 1A′), indicating that Ab themselves acted as an inert
electron- and mass-transfer blocking layer. The binding of T cells to
anti-CD3-modiﬁed Au/PANI-NFs further hindered the access of
redox probes to the electrode, leading to a higher Ret value
(curve d, Fig. 1A′). Because CD3 molecules were widely expressed
on resting T-cell surface, the value implicated that T cells were
successfully captured by the cytosensor. Based on the successful
capture and measuring of CD3 on resting cells, we further0 200 400 600 800 1000 1200 1400
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h (control), 8 h, 24 h and 36 h. Note that a lack of increases in CD3 expression after
s to form nanoclusters or nanodomains, instead of increases in total amounts of
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ing with anti-CD69, anti-CD25 and anti-CD71 Abs, respectively,
and subsequently with activated T cells for measuring EIS signals
for CD69 (Fig. 1B′), CD25 (Fig. 2C′) and CD71 (Fig. 1D′) activation
molecules on surface of activated cells. Notably, compared with CV
characterization (Fig. 1B, C and D), CD69-targeted, CD25-targeted
or CD71-targeted cytosensor was able to measure remarkable EIS
signals representing each of these cellular activation markers on
surface of activated T cells captured on the electrode surface
(Fig. 1B′, C′ and D′). The result suggests that anti-CD molecules
conjugations in the interface can speciﬁcally recognize T-cell
activation markers on cellular membrane, and effectively capture
living cells for biosensing (Figs. 1 and 2).
Increases in magnitude of ΔRet correlated with the number of
cells speciﬁcally bound to the electrode. This relationship
appeared depend on the numbers of binding sites on cells
captured by the antibody-immobilized electrode, and thus reﬂect
the amount of targeted T-cell activation markers expressed on cell
surface (Ding et al., 2009). We showed optimal concentrations for
capturing cells on interface was 1104 cells/ml, which was much
fewer than 3105 and 9.5105 cells/ml required in antibody
array-based methods (Hsu et al., 2006; Tateno et al., 2007). Our
improved detection of limit might be due to effective increases in
binding sites of Au/PANI-NFs nanocomposites for cell binding and
electrical connectivity.
3.3. Immune characterization of activation marker-targeted
cytosensor for sensing T-cell activation
We then further characterized the activation marker-targeted
cytosensor. Since ConA functioned as immune stimulator to
activate resting T cells (Guo et al., 2012), we used activation
marker-targeted cytosensors to assess the surface expressions of
3 different surface activation markers (CD69, CD25 and CD71)
representing early, middle and late activation stages, respectively,
after ConA stimulation. As shown in Fig. 1B′, C′ and D′, Au/PANI-
NFs-based cytosensor that targeted activation marker CD69, CD25
or CD71 could readily sensitize expression of surface activation
molecules of activated T cells. To conﬁrm the activation status of
ConA-stimulated cells, we also used ﬂow cytometry to analyze
proliferating cells in CSFE ﬂuorescence dye-labeled peripheral
blood mononuclear cells (PBMC) as CFSE would be diluted after
the labeled cells proliferated in response to ConA stimulation.
ConA-stimulated T cells exhibited increased proliferation from
1.13% to 64.56% after 72 h stimulation (Supp. Fig. 2). Consistently,
ConA-stimulated T cells showed an increased expression of activa-
tion markers CD69, CD25 or CD71, as T cells stimulated for 8 h,
24 h and 36 h increased their expressions of CD69, CD25, and
CD71 up to 84.3%, 70.5%, and 83.4%, respectively, from baseline
level o10% of total CD3+ T cells (Supp. Fig. 3). This result
supported previous reports of activation (Hu et al., 2009; Chen
et al., 2009; Shipkova and Wieland, 2012).
To visualize activated cells whose activation molecules or
signals were detected by activation marker-targeted cytosensors,
we took advantage of the observation that FITC-labeled T cells
could give rise to green ﬂuorescence due to FITC ﬂuorescence
spectrum, and examined if ﬂuorescent microscopy could allow us
to directly see activated T cells captured by antibody-coupled Au/
PANI-NFs electrode surface. As shown in Supp. Fig. 4, FITC-labeled
T cells were observed. In fact, increases in numbers of activated
FITC-labeled T cells correlated with greater capability of the
cytosensor to detect activation efﬁciency of Au/PANI-NFs interface.
This result demonstrated that biomimetic antibody-functionalized
interface could preserve the activity of captured cells for subse-
quent detection. To further characterize the surface ultrastructure
of an activated cell captured by the cytosensor, we used AFM fordetailed visualization. AFM images showed synapse-like morphol-
ogies on cell surface of a single T-cell (Supp. Fig. 5), suggesting that
CD69, CD25 or CD71 might contribute to changes in physiological
property of cell membrane.
3.4. Immune features of activation marker-targeted cytosensor for
sensing immune activation
We then determined the utility of activation marker-targeted
cytosensors, and analyzed dynamic changes in T cell-surface CD
molecules during activation and immune inhibition of activation.
Au/PANI-NFs-based cytosensors were then immobilized with anti-
CD69, anti-CD25, and anti-CD71 Abs to monitor alteration of these
T-cell surface activation markers in response to timely ConA
stimulation. At the same cell concentrations, T cells were activated
into different activation stages in the presence of ConA from 0 to
36 h. Cells were then loaded on the activation marker-targeted
cytosensor, and detected by EIS measurements. Interestingly,
while there were no or very low EIS signals detected by the
Ab-immobilized electrode without cells loaded or the electrode
surface loaded with resting cells (control), remarkable EIS signals
were detected by the activation marker-targeted cytosensors
immobilized by activated cells stimulated by ConA for 8 h, 24 h
or 36 h, especially for 36 h (Fig. 2). Compared with label-free
optical microscopy method (Zheng et al., 2005; Chen et al., 2007),
our cytosensors appeared to be simpler and more sensitive as a
result of coupling with dual signal ampliﬁcation of Au/PANI-NFs
with PANI-NFs-based electrochemical measurements. Thus, a
combination of the speciﬁc binding to membrane CD molecules
and dual signal ampliﬁcation of Au/PANI-NFs made it possible to
develop a highly sensitive method to quantitatively sensitize cell-
activation or signaling molecules on T-cell surface.
Under the optimal concentrations for captured cells, the ΔRet of
EIS could be used to quantify the amount of anti-CD Ab molecules
that bound to the captured T-cells. This in turn allowed us to
estimate the quantity of CD molecules on the cell surface. Based on
ConA-activated T cells, the ΔRet values obtained at four working
electrodes incubating with same numbers of cells led to develop-
ment of optimal antibody concentrations in the order (Supp.
Table 1): anti-CD3 (20 μg/ml) 4 anti-CD71 (15 μg/ml) 4 anti-
CD25 (10 μg/ml) 4 anti-CD69(5 μg/ml). These results allowed us
to estimate the expression levels of different CD molecules on
T-cell surfaces after cell activation for 8–36 h, suggesting high
expression of CD3, moderate expression of CD71, low expression of
CD25 and little expression of CD69 molecules on the T-cell surface.
Because CD3 molecules were widely expressed on T-cell surface,
high abundance of CD3 on cell were observed. CD71 molecules,
late activation marker of T-cells, have moderate abundance on
activated T-cell surface. Low or little expression of.CD69 and CD25
molecules consisted with early and middle activation stage of
T cells.
CD molecule proﬁles obtained by electrochemical cytosensors
appear to give quantitative comparisons for CD molecules on T
cells. The signal of cell binding could directly be observed during
EIS detection, which was more quantitative and facile than
microscopic observation (Tateno et al., 2007). Although the pro-
posed method could not provide molecular details, it allowed us to
gain insight into the biologically relevant surface-accessible T-cell
activation marker motifs.
3.5. Speciﬁcity and utility of activation marker-targeted cytosensors
for sensing immune activation
Notably, the electrochemical detection appeared to be speciﬁc,
hardly showing any background signal for antibody-free control
(curve b, Fig. 1A′, B′, C′ and D′). This electrochemical strategy could
H. Wang et al. / Biosensors and Bioelectronics 50 (2013) 167–173172be used to obtain more sensitive proﬁles of low-expressing CD
molecules, such as CD69, than ﬂow cytometric analysis with FTIC-
labeled antibodies owing to the background auto-ﬂuorescence of
cells (Supp. Fig. 3). Thus, the proposed strategy could accurately
evaluate expression statuses of multiple CD molecules during
different activation T-cell stages via EIS as electrochemical signals.
The results suggest that our novel strategy integrates the advan-
tages of nanotechnology, bioconjugation, nanoparticle-based sig-
nal ampliﬁcation and electrochemical detection, and provides a
useful tool for dynamic monitoring of changes in expressions of
T-cell activation/signaling markers during the biological processes.
To further validate the speciﬁc recognition of T-cell activation
markers by anti-CD Ab molecules on Au/PANI-NF interfaces, red
mouse blood cells or activated T cells were loaded on electrode
surface of activation marker-targeted cytosensors, and assessed for
EIS signals (Supp. Fig. 6). The ΔRet value of red blood cells loaded
on anti-CD69, anti-CD25 and anti-CD71-immobilized electrodes
was average 30 Ω, whereas speciﬁc recognition ΔRet values of
150 Ω or higher were seen on the cytosensors loaded with
activated T cells (Supp. Fig. 6). Such low value for red blood cells
could be explained by the fact that unlike T cells, red blood cell
surface did not express any CD antigens, and therefore Au/PANI-
NFs-based cytosensors were not able to capture any red blood cells
for sensitization. This ﬁnding suggested that CD antigen-targeted
cytosensors could speciﬁcally recognize surface CD antigens of
T-cells and, accordingly, T-cell activation markers. Thus, the
activation-targeted cytosensors also exhibited considerable speci-
ﬁcity as these CD cytosensors did not bind or sensitize any
detectable signals for red blood cells, which do not express CD
molecules on cell surface.
We then evaluate the utility of activation marker-targeted
cytosensors for sensing immune activation. The activation
marker-targeted cytosensors readily immobilized and detected
early, middle and late activation signals of activate T cells, as
expressions of CD69, CD25 and CD71 were distinctly revealed on
the activated cells stimulated by ConA for 8 h, 24 h or 36 h,
especially for 36 h (Fig. 2). Supp. Fig. 7 summarizes the complete
ΔRet signals over time after T-cell activation and capturing of
activated T cells by activation marker-targeted cytosensors. The
ΔRet signals detected on anti-CD69, anti-CD25, or anti-CD71-
captured cells were increased when increasing activation times.
Of note, ΔRet signals on CD69-targeted cytosensor tended to peak
at 8 h and reach plateau at 24 h and 36 h. In contrast, CD25- and
CD71-targeted cytosensors reached peaks at 24 h and 36 h,
respectively, with plateau being seen thereafter. These results
were consistent with the scenario that CD69, CD25 and CD71
represent early, middle and late activation surface markers,
respectively, mimicking different stages of cellular activation (Hu
et al., 2009). The high expressions of CD69, CD25 and CD71 over
time after activation were also consistent with the data obtained
by ﬂow cytometric analysis using ﬂuorescence dye-conjugated
antibodies (Supp. Fig. 3). However, a small change in ΔRet signals
was seen over time for anti-CD3 Ab-targeted cytosensor loaded
with activated cells (Supp. Fig. 7). This might be due to the fact
that there was a lack of increased expression of CD3 molecules on
cell surface after ConA stimulation although CD3 molecules could
undergo nanoscale redistribution forming nanoclusters or nano-
domains (Zhong et al., 2009). Consistently, remarkable increases in
the ΔRet value were detected on the anti-CD69, anti-CD25 and
anti-CD71-immobilized cytosensors, once these cytosensors were
loaded with ConA-activated T cells (Supp. Fig. 6).
Finally, we examined whether the activation marker-targeted
cytosensors could sensitize dynamic changes in surface activation
molecules in responses to suppression of T-cell activation by an
immune regulatory drug. We used Icariin (ICA) as an inhibitory
drug as it could inhibit T-cell activation and signiﬁcantly inﬂuenceactivation markers expression on cell surface (Chen et al., 2005).
CD69- and CD25-targeted cytosensors loaded with ICA-treated
ConA-stimulated T cells showed 30% and 13% decreases in ΔRet
values, respectively, when compared with the ConA-stimulated
cells without ICA treatment (Supp. Fig. 8). However, almost no
change was seen for CD71-targeted cytosensors loaded with ICA-
treated ConA-stimulated T cells. This result indicated that the
ConA-driven expression of CD69 and CD25 on cell surface was
sensitive to ICA treatment as previously reported (Zhou et al.,
2011), and that CD69- and CD25-targeted cytosensors could detect
ICA-mediated down-regulation of CD69 and CD25 expression by
ConA-stimulated T cells. The inter-assay imprecision for detection
of activation markers on T-cell surface by the designed cytosensors
was investigated using three kinds of the designed cytosensors
employing one cell sample at the same time. The inter-assay
variation coefﬁcient (CV) was less than 8.7%, implicating accep-
table reproducibility.
Thus, activation marker-targeted cytosensors appear to exhibit
versatile speciﬁcity and utility for sensing immune activation of
T cells. The activation-targeted cytosensors seem to be advanta-
geous over those biochemistry assays such as mass spectroscopy,
and chromatography in terms of multiple tests of activation events
of living T cells in responses to activation stimuli. Importantly,
compared to ﬂow cytometry assays, our novel cytosensors appear
to be following versatile features: (i) much smaller numbers of
blood lymphocytes needed for assays; (ii) simple and fast sample
preparation for analyses; (iii) no need for ﬂuorescence labeling of
Ab and cells; (iv) inexpensiveness and simplicity for running
assays. These features are in quite contrasts to expensive ﬂow
cytometry/operators and complicated ﬂow operating systems. The
key characteristic of simple/fast evaluation of T-cell activation may
have some potential application for designing versatile cytosen-
sors for guiding diagnosis and treatment of inﬂammations, infec-
tions or cancers.4. Conclusion
Thus, Au/PANI-NFs nanocomposites could efﬁciently immobi-
lize anti-CD antibodies, and serve as novel electrochemical cyto-
sensors. While activation-targeted cytosensors were considerably
speciﬁc, they were able to detect expressions of CD69, CD25, and
CD71, respectively, during early, middle and late stages of T-cell
activation, and detect immune-regulatory drug inhibition of ConA-
stimulated T-cell activation. Our results suggest that surface
molecules-targeted Au/PANI-NFs cytosensors may represent sim-
ple, fast and efﬁcient methods to quantitatively detect expression
of activation/signaling molecules on membrane of immune cells.
Findings have potential application for developing versatile cyto-
sensors for guiding clinical evaluation of inﬂammations, infections
or cancers.Acknowledgments
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